Cephalexin (Ranceph)
Cephalexin
Ranbaxy (SA) (Pty) Ltd
Registration
- Applicant
- Ranbaxy (SA) (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ranceph 250 capsules EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO 250,0 mg CEPHALEXIN | 250Capsules | 30033430/20.1.1/0334 | Registered | Not determined | None |
| Ranceph 500 capsules EACH CAPSULE CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 500,0 mg | 500Capsules | 30033530/20.1.1/0335 | Registered | Not determined | None |
| Ranceph suspension 125 mg/ 5ml EACH 5,0 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 125,0 mg | 125 mg/ 5MLSuspension | 32021432/20.1.1/0214 | Registered | Not determined | None |
| Ranceph suspension 250 mg/5 ML EACH 5,0 ml SUSPENSION CONTAINS CEPHALEXIN MONOHYDRATE EQUIVALENT TO CEPHALEXIN 250,0 mg | 250 mg/5 MLSuspension | 32021532/20.1.1/0215 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 27447.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.